Pharmafile Logo

The Trust Test

- PMLiVE

Weekly industry appointments

GSK’s CSO cell and gene therapy heads for the exit, Gelesis adds to company, Abcam appoints Peter Allen and Joseph Swedish joins Mesoblast’s board

- PMLiVE

Irish survey lists pharma firms’ top five Brexit concerns

Talent access restrictions topped the list

Improving Outcomes – Patient Engagement & Activation

Last week, Lucid launched its first Thirsty Thursday session, during which everyone gets an opportunity to quench their thirst for knowledge and learn about new industry trends and techniques. Last...

Lucid Group Communications Limited

- PMLiVE

Sarepta soars on positive Duchenne data

Trial results position Sarepta as a “leader in the field” according to analysts

Surgeons_A lesson from history_Patient outcomes

It’s all about patient outcomes… right?

Lessons from history: a design thinking perspective

Porterhouse Medical Group

- PMLiVE

Got marketing ambition? You need to master biases of cognition

Unlocking the potential of cognitive bias

30 Women Leaders in UK Healthcare (part 3)

Continuing our special feature on Women Leaders in UK Healthcare

- PMLiVE

30 Women Leaders in UK Healthcare

The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future

- PMLiVE

30 Women Leaders in UK Healthcare (part 2)

Part two of our list of thirty women leaders 11-20

- PMLiVE

Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte

Alexander Davies considers the remarkable story of how one company broke with pharma convention to speak out on social media

- PMLiVE

The Directory and digital round-up

SOPHiA Genetics acquires IBS, Kyomed becomes KYomed INNOV and launches ePRO, Medtronic unveil diabetes app

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links